We are live on ! Find out more
QTTB icon

Q32 Bio
QTTB

57 hedge funds and large institutions have $11.4M invested in Q32 Bio in 2023 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 6 increasing their positions, 11 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.09% more ownership

Funds ownership: 1.71% → 1.8% (+0.09%)

0% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 10

2% less funds holding

Funds holding: 58 → 57 (-1)

45% less capital invested

Capital invested by funds: $20.8M → $11.4M (-$9.38M)

45% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 11

Holders
57
Holders Change
-1
Holders Change %
-1.72%
% of All Funds
0.83%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
6
Reduced
11
Closed
10
Calls
$21K
Puts
–
Net Calls
+$21K
Net Calls Change
-$54K

Top Buyers

Rank Fund Capital Flow
1
NM
Newtyn Management
New York
+$1.14M
2
BCM
BML Capital Management
Indiana
+$608K
3
GKFF
George Kaiser Family Foundation
Oklahoma
+$217K
4
XT
XTX Topco
Cayman Islands
+$27.5K
5
VF
Virtu Financial
New York
+$27.4K

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$658K
2
WSL
Western Standard LLC
California
-$293K
3
BCM
Bridgeway Capital Management
Texas
-$217K
4
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$138K
5
Bank of America
Bank of America
North Carolina
-$94.3K
Name Holding Trade Value Shares
Change 		Change in
Stake
Assenagon Asset Management
26
Assenagon Asset Management
Luxembourg
$22.7K +$10.5K +721 +53%
AIS
27
American Investment Services
Massachusetts
$22.5K – – –
VF
28
Virtu Financial
New York
$21K +$27.4K +1,877 New
SIA
29
Schechter Investment Advisors
Michigan
$18.1K – – –
Morgan Stanley
30
Morgan Stanley
New York
$15.9K +$10.7K +730 +101%
Goldman Sachs
31
Goldman Sachs
New York
$15.1K -$497 -34 -2%
Jane Street
32
Jane Street
New York
$14.4K +$19.2K +1,314 New
Charles Schwab
33
Charles Schwab
California
$13.4K – – –
Mariner
34
Mariner
Kansas
$12.1K – – –
Bank of New York Mellon
35
Bank of New York Mellon
New York
$11.8K – – –
Millennium Management
36
Millennium Management
New York
$10.5K -$82.2K -5,622 -85%
HSBC Holdings
37
HSBC Holdings
United Kingdom
$9.32K – – –
UBS Group
38
UBS Group
Switzerland
$8.27K -$687 -47 -6%
RJA
39
Raymond James & Associates
Florida
$7.86K -$2.43K -166 -19%
DCM
40
Dimension Capital Management
Florida
$6.66K – – –
TYCC
41
Texas Yale Capital Corp
Florida
$6.08K – – –
Corient Private Wealth
42
Corient Private Wealth
Florida
$6.08K +$8.13K +556 New
Wells Fargo
43
Wells Fargo
California
$1.03K – – –
AWM
44
Ameliora Wealth Management
Switzerland
$912 – – –
RhumbLine Advisers
45
RhumbLine Advisers
Massachusetts
$713 – – –
JP Morgan Chase
46
JP Morgan Chase
New York
$580 – – –
FDCDDQ
47
Federation des caisses Desjardins du Quebec
Quebec, Canada
$444 – – –
ASN
48
Advisory Services Network
Georgia
$423 +$570 +39 New
NA
49
NewEdge Advisors
Louisiana
$279 – – –
Osaic Holdings
50
Osaic Holdings
Arizona
$170 – – –
1
2
3

QTTB Hedge Fund Activity: Q4 2023 in Review

57 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Q32 Bio (QTTB) for Q4 2023, worth a combined $11.4M — down 45% from $20.8M a quarter earlier.

Fund positioning in QTTB was balanced in Q4 2023: 10 funds opened new positions, 10 closed out, 6 added to existing stakes and 11 trimmed.

The largest buyer was Newtyn Management, opening a new position worth an estimated $1.14M. The largest seller was Citadel Advisors, cutting an estimated $658K.

  • 57 institutional investors held Q32 Bio (QTTB) as of Q4 2023, down from 58 in Q3 2023.
  • Funds reported $11.4M of Q32 Bio stock for Q4 2023, down 45% quarter-over-quarter.
  • 10 funds opened new Q32 Bio positions in Q4 2023 and 10 closed out, a net change of 0 holders.
  • The largest Q32 Bio buyer in Q4 2023 was Newtyn Management, an estimated $1.14M added.
  • The largest Q32 Bio seller in Q4 2023 was Citadel Advisors, an estimated $658K sold.

Based on aggregated 13F filings for Q4 2023.